MedPath

Effects of a combined telechoaching and telemonitoring programme in heart failure patients

Conditions
I50
Heart failure
Registration Number
DRKS00026197
Lead Sponsor
Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Klinik an der Technischen Universität München
Brief Summary

In a real-life setting of ambulatory HF patients at high risk for re-hospitalisation, participation in a comprehensive telehealth programme lead to reduced number of hospitalisations for HF (17.9 vs. 21.8 per 100 patient years, p < 0.001) and all-cause hospitalisations (129.0 vs. 133.2 per 100 patient years, p = 0.015) and was also related to a significant reduction in all-cause mortality compared to usual care (5.8 vs. 11.0 %, p < 0.001).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
12130
Inclusion Criteria

1. hospital discharge with heart failure diagnosis (ICD-10-GM I50*, I11.0*, I13.0*, I42.0) within past 18 months.
2. =40 years of age.
3. Likelihood of Hospitalization =37.75% within the next 12 months.

Exclusion Criteria

- Chronic kidney disease stage 4 or 5 (N18.4 or N18.5)
- cardiac assist device (Z95.80)
- dementia (F00*-F03*)
- dependency syndromes (F10.2, F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F19.2)
- schizophrenia (F20-F29)
- Alzheimer disease (G30.0, G30.1, G30.8, G30.9)
- lack of legal capacity
- nursing home residence or very high level of nursing care requirement
- severely impaired hearing or sight

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All-cause Mortality
Secondary Outcome Measures
NameTimeMethod
- Re-Hospitalisation (all-cause, for heart failure, cardiovascular). <br>- Days alive and out of hospital.<br>- Subjective assessment of quality of life, self-perceived health status and self-care in the telemedical care group over time.
© Copyright 2025. All Rights Reserved by MedPath